Boston Life Sciences, Inc. To Present at the Sachs Associates 6th Annual North America Forum for Investing & Partnering in Biote
07 Marzo 2007 - 10:00AM
PR Newswire (US)
HOPKINTON, Mass., March 7 /PRNewswire-FirstCall/ -- Boston Life
Sciences, Inc. (NASDAQ:BLSI) today announced that Ken Rice,
Executive Vice President and Chief Financial Officer of Boston Life
Sciences, Inc., will be presenting a Company update at the Sachs
Associates 6th Annual North America Forum for Investing &
Partnering in Biotech on Monday, March 12 at 10:55am EDT. The
conference is being held on March 12 at the Fairmont Copley Plaza
in Boston, MA. The Boston Life Sciences presentation will be
available by webcast. Access to the webcast will be available
within the Investor Relations section of the Boston Life Sciences
website at http://www.bostonlifesciences.com/. About Boston Life
Sciences, Inc. Boston Life Sciences, Inc. (BLSI) is engaged in the
research and clinical development of diagnostic and therapeutic
products for central nervous system (CNS) disorders. ALTROPANE(R)
molecular imaging agent is in Phase III clinical trials for the
diagnosis of Parkinson's Disease (PD) and Phase II clinical trials
for the diagnosis of Attention Deficit Hyperactivity Disorder
(ADHD). Cethrin(R), a recombinant-protein-based drug designed to
promote nerve repair after acute spinal cord injury, has reported
positive interim results in a North American Phase I/IIa clinical
trial. The company's research and pre- clinical CNS programs
include Inosine for the treatment of spinal cord injury and stroke,
a DAT blocker for the treatment of Parkinson's disease, and a
second generation technetium-based molecular imaging agent for PD
and ADHD. BLSI's current research collaborations include Harvard
Medical School and Children's Hospital Boston. Contact: Meredith
Patin -- 508-497-2360 ext 239 Boston Life Sciences, Inc.
DATASOURCE: Boston Life Sciences, Inc. CONTACT: Meredith Patin of
Boston Life Sciences, Inc., +1-508-497-2360, ext. 239, or Web site:
http://www.bostonlifesciences.com/
Copyright
Boston Life Sciences (NASDAQ:BLSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Boston Life Sciences (NASDAQ:BLSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Boston Life Sciences (MM) (NASDAQ): 0 recent articles
Más de Boston Life Sciences (MM) Artículos de Noticias